5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of a 5-Fluorouracil (5-FU)
and interferon, which is able to stimulate the immune system to kill cancer cells, will help
to increase tumor shrinkage in previously-treated metastatic gastrointestinal, kidney, or
lung Cancer.